We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

92 hedge funds and large institutions have $60.8M invested in iShares US Pharmaceuticals ETF in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 32 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more call options, than puts

Call options by funds: $1.14M | Put options by funds: $800K

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

3% less funds holding

Funds holding: 95 → 92 (-3)

15.08% less ownership

Funds ownership: 81.14% → 66.05% (-15%)

31% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 32

37% less capital invested

Capital invested by funds: $96.2M → $60.8M (-$35.4M)

Holders
92
Holders Change
-3
Holders Change %
-3.16%
% of All Funds
2.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
22
Reduced
32
Closed
11
Calls
$1.14M
Puts
$800K
Net Calls
+$344K
Net Calls Change
+$693K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.05M
2
RJA
Raymond James & Associates
Florida
+$2.64M
3
SRSA
S.R. Schill & Associates
Washington
+$1.46M
4
CG
Cutler Group
California
+$424K
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$281K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$15.1M
2
Fisher Asset Management
Fisher Asset Management
Washington
-$5.4M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$3.29M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.45M
5
Bank of America
Bank of America
North Carolina
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASN
76
Advisory Services Network
Georgia
$27K -$2.42K -48 -7%
FFW
77
Fusion Family Wealth
New York
$23K – – –
HWA
78
HHM Wealth Advisors
Tennessee
$20K +$22.7K +450 New
Fifth Third Bancorp
79
Fifth Third Bancorp
Ohio
$19K – – –
William Blair & Company
80
William Blair & Company
Illinois
$19K – – –
EWM
81
EPG Wealth Management
Georgia
$14K +$10.3K +204 +194%
DSC
82
Duncker Streett & Co
Missouri
$13K – – –
HGWM
83
Harvest Group Wealth Management
Massachusetts
$10K – – –
NFG
84
Next Financial Group
Texas
$8K – – –
AA
85
AlphaMark Advisors
Kentucky
$7K – – –
S
86
SignatureFD
Georgia
$7K – – –
TPWA
87
TRUE Private Wealth Advisors
Oregon
$5K – – –
BCWM
88
Bartlett & Co Wealth Management
Ohio
$4.04K – – –
BC
89
Bartlett & Co
Ohio
$4K +$4.54K +90 New
BWA
90
BDO Wealth Advisors
Florida
$2K +$2.27K +45 New
MWM
91
MBE Wealth Management
Wisconsin
$2K +$2.72K +54 New
MCM
92
Manchester Capital Management
Vermont
$1K – – –
CI
93
Clal Insurance
Israel
– -$140K -67,254 Closed
Cerity Partners
94
Cerity Partners
New York
– -$284K -5,316 Closed
NFC
95
Northeast Financial Consultants
Connecticut
– -$221K -4,140 Closed
SG
96
StoneX Group
New York
– -$218K -4,080 Closed
AFC
97
AFT Forsyth & Company
Florida
– -$217K -4,074 Closed
PAG
98
Private Advisor Group
New Jersey
– -$207K -3,876 Closed
TCWM
99
Total Clarity Wealth Management
Illinois
– -$80K -1,500 Closed
TI
100
tru Independence
Oregon
– -$8K -180 Closed
1 2 3
4
5

IHE Hedge Fund Activity: Q1 2020 in Review

92 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q1 2020, worth a combined $60.8M — down 37% from $96.2M a quarter earlier.

Fund positioning in IHE was balanced in Q1 2020: 11 funds opened new positions, 11 closed out, 22 added to existing stakes and 32 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $3.05M. The largest seller was Goldman Sachs, cutting an estimated $15.1M.

  • 92 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q1 2020, down from 95 in Q4 2019.
  • Funds reported $60.8M of iShares US Pharmaceuticals ETF stock for Q1 2020, down 37% quarter-over-quarter.
  • 11 funds opened new iShares US Pharmaceuticals ETF positions in Q1 2020 and 11 closed out, a net change of 0 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q1 2020 was Susquehanna International Group, an estimated $3.05M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q1 2020 was Goldman Sachs, an estimated $15.1M sold.

Based on aggregated 13F filings for Q1 2020.